Sites: CDL-Oxford, CDL-Toronto, CDL-Vancouver, CDL-Wisconsin
Stream: Advanced Therapies
Anna Jezierski received her PhD at the University of Ottawa in molecular and cellular medicine and completed her post-doctoral studies in science policy at Health Canada in the health products and food branch. She is currently a research officer at the Human Health Therapeutics Research Centre at the National Research Council of Canada and an adjunct professor in the department of biochemistry, microbiology and immunology at the University of Ottawa. Her expertise is focused on leveraging human induced pluripotent stem cells (iPSCs) as cell chassis for advancing disease modeling, drug discovery and engineered cell-based therapies for applications in regenerative medicine and immunotherapies. More specifically, Anna’s area of focus is in evaluating blood brain barrier permeability of central nervous system targeting (bio)therapeutics and off-the-shelf NK based therapies.